News FTSE 100

Index

UKX

GB0001383545

Market Closed - Great Britain 16:50:00 31/05/2024 BST			5-day change	1st Jan Change
8,275 ^PTS	+0.54%		-0.51%	+7.01%

05-25	Sunak's summer election brings hope to Britain's bruised financial sector	RE
05-24	IWG confirms name change to International Workplace Group	AN

All news about FTSE 100

ONLINE FASHION GIANT SHEIN TO FILE PROSPECTUS FOR £50BN LONDON F…	06-02	RE
London Stocks Rally Amid US, Eurozone Inflation Data	05-31	MT
FTSE 100 rounds off decent May with gain	05-31	AN
Wall Street Set to Open Modestly Higher Friday as Key Inflation Data Meets Expectations	05-31	MT
FTSE 100 outperforms European counterparts	05-31	AN
Renewable Energy Company Cindrigo Delists from London Bourse	05-31	MT
UK-based CFO leaves Flutter as US becomes primary listing	05-31	AN
Flutter Entertainment Changes Primary Listing to NYSE	05-31	MT
FTSE 100 up as markets wait for US PCE reading	05-31	AN
London stocks little changed as US, Euro inflation data loom	05-31	RE
FTSE 100 called up; UK house prices show resilience	05-31	AN
Investors nervously eye key US PCE reading	05-31	AN
Alliance News UK - start of day	05-31	AN
AB Foods majority investor to sell GBP273 million worth of shares	05-30	AN
Auto Trader Group Drives UK's FTSE 100 Index Recovery	05-30	MT

News of the index components

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Astra's Enhertu breast cancer trial shows 'unprecedented' results AZN	06-02	RE
TAGRISSO® (osimertinib) reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial AZN	06-02	BU
AstraZeneca : Tagrisso reduced the risk of disease progression or death by 84% in patients with unresectable, Stage III EGFR-mutated lung cancer vs. placebo in LAURA Phase III trial AZN	06-02	PU
GSK Says Belantamab Mafodotin Combination Reduced Risk Of Disease Progression Or Death By Nearly 50% In Relapsed/Refractory Multiple Myeloma GSK	06-02	RE
Astra's Enhertu delays breast cancer in patients with low HER2 levels AZN	06-02	RE
GSK : Blenrep combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma GSK	06-02	PU
Belantamab Mafodotin combination reduced the risk of disease progression or death by nearly 50% versus standard of care combination in relapsed/refractory multiple myeloma GSK	06-02	BU
IMFINZI® (durvalumab) is the first and only immunotherapy to show survival benefit in limited-stage small cell lung cancer in global Phase III trial, reducing the risk of death by 27% vs. placebo AZN	06-02	BU
Astrazeneca Safety Profile Of Enhertu Was Consistent With Previous Breast Cancer Clinical Trials With No New Safety Concerns Identified AZN	06-02	RE
ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 13.2 months in HR-positive, HER2-low and HER2-ultralow metastatic breast cancer following one or more lines of endocrine therapy AZN	06-02	BU
GSK blood cancer drug nearly halves risk of death in late-stage trial GSK	06-02	RE
Delaware judge lets more than 70,000 Zantac lawsuits go forward GSK	06-01	RE
GSK Regarding Ruling By Delaware State Court On Zantac Litigation Will Immediately Seek Appeal GSK	06-01	RE
Materials Companies Rise As Metals Extend Gains -- Materials Roundup RIO	05-31	DJ
Fusion Pharmaceuticals Gets Court Order Approving AstraZeneca Deal AZN	05-31	MT

No results for this search

News in other languages on FTSE 100

Borsa: l'Europa chiude a due velocità	05-31
BlackRock: IBIT wordt 's werelds grootste Bitcoin ETF - cryptonieuws	05-30
Listini in verde; focus su inflazione di domani	05-30
BlackRock: IBIT se convierte en el mayor ETF de Bitcoin del mundo - Crypto Recap	05-30
Actualización de las fuertes variaciones del día: Dr Martens, LDC, OVH Groupe, Neoen y muchos otros.	05-30
BlackRock: IBIT diventa l'ETF Bitcoin più grande al mondo - Crypt On It	05-30
BlackRock : L'IBIT devient le plus grand ETF Bitcoin au monde - Crypt On It	05-29
Borse in rosso; scatto di DiaSorin sul Mib	05-29
Actualización de las fuertes variaciones del día: Ocado, Waga Energy, Volkswagen y otros	05-29
Les actions en mouvement : Ocado, Waga Energy, Volkswagen, et d'autres	05-29
Les Bourses mondiales en repli, évitant les prises de risque	05-29
Borsa: Europa debole in apertura, Parigi -0,3%, Londra -0,1%	05-29
Les Bourses prudentes avant des données sur l'inflation, record pour le Nasdaq	05-28
Mib in rosso; BPER e Intesa resistono ai ribassi	05-28
Borsa: Europa conclude negativa	05-28

Headlines

London stocks little changed as US, Euro inflation data loom

London stocks little changed as US, Euro inflation data loom

May 31, 2024 at 08:34 am

London Stocks Flat as Optimism for Looming Rate Cuts Grows

April 03, 2024 at 04:54 pm

Taiwan & TSMC: Linked fate

May 29, 2024 at 09:07 am

Taiwan & TSMC: Linked fate

Hard times for Superdry and Dr. Martens

April 16, 2024 at 04:24 pm

Hard times for Superdry and Dr. Martens

Euronext N.V. : A monopoly at a discount

October 16, 2023 at 04:58 pm

Euronext N.V. : A monopoly at a discount

UK inflation reading is cause for concern

August 16, 2023 at 09:38 am

UK inflation reading is cause for concern

TI Fluid Systems plc : Star of the day in the UK

August 08, 2023 at 04:14 pm

TI Fluid Systems plc : Star of the day in the UK

Rankings

Highest FTSE 100 increases
NATIONAL GRID PLC	+4.67%
SSE PLC	+2.27%
SEVERN TRENT PLC	+2.14%
GSK PLC	+2.11%
RECKITT BENCKISER GROUP PLC	+1.92%

The sharpest declines in FTSE 100.
BURBERRY GROUP PLC	-1.80%
OCADO GROUP PLC	-2.58%
ASSOCIATED BRITISH FOODS PLC	-4.14%
JD SPORTS FASHION PLC	-4.71%
EVRAZ PLC	-12.59%

See the ranking

% Price Change by Sector

ETF components Vanguard FTSE 100 UCITS ETF

Detailed heatmap

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW